Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Purpose: Stereotactic body radiotherapy (SBRT) for stage I non–small-cell lung cancer (NSCLC) is associated with high local control rates. The impact of introducing SBRT in patients 75 years of age or older was studied using a population-based cancer registry. Methods: The Amsterdam Cancer Registry was assessed in three eras: 1999 to 2001 (period A, pre-SBRT); 2002 to 2004 (period B, some availability of SBRT), and 2005 to 2007 (period C, full access to SBRT). χ 2 , Kaplan-Meier, and Cox regression were used to compare treatment patterns and overall survival (OS) in three treatment groups: surgery, radiotherapy (RT), or neither. Results: A total of 875 elderly patients were diagnosed with stage I NSCLC in the study period. Median follow-up was 54 months. Primary treatment was surgery in 299 patients (34%), RT in 299 patients (34%), and neither in 277 patients (32%). RT use increased between periods A and C (26% v 42%, P < .01), corresponding to a decrease in untreated patients. The percentage of RT patients undergoing SBRT in periods B and C was 23% and 55%, respectively. Median survival for all patients increased from 16 months in period A to 21 months in period C (log-rank P < .01; hazard ratio [HR] = 0.65; 95% CI, 0.54 to 0.80). The improvement in OS was confined to RT patients (HR = 0.70; 95% CI, 0.49 to 0.99), whereas no significant survival improvements were seen in the other groups. Conclusion: SBRT introduction was associated with a 16% absolute increase in RT use, a decline in the proportion of untreated elderly patients, and an improvement in OS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
Timmerman, R. (2010) · JAMA · doi:10.1001/jama.2010.261 · Cited by 2,532
Edwards, B. K., Howe, H. L., Ries, L. A. G., Thun, M. J., Rosenberg, H. M., Yancik, R., Wingo, P. A., Jemal, A., & Feigal, E. G. (2002) · Cancer · doi:10.1002/cncr.10593 · Cited by 880
(2016) · Diagnostic Imaging: Nuclear Medicine · doi:10.1016/b978-0-323-37753-9.50111-0 · Cited by 855
van Tinteren, H., Hoekstra, O. S., Smit, E. F., van den Bergh, J. H., Schreurs, A. J., Stallaert, R. A., van Velthoven, P. C., Comans, E. F., Diepenhorst, F. W., Verboom, P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08352-6 · Cited by 851
Swensen, S. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440290031002 · Cited by 810
Owonikoko, T. K., Ragin, C. C., Belani, C. P., Oton, A. B., Gooding, W. E., Taioli, E., & Ramalingam, S. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.5435 · Cited by 566
Morgensztern, D., Ng, S. H., Gao, F., & Govindan, R. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c5920c · Cited by 547
Lagerwaard, F. J., Haasbeek, C. J. A., Smit, E. F., Slotman, B. J., & Senan, S. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.10.053 · Cited by 534
Self-citationGould, M. K., Ananth, L., & Barnett, P. G. (2007) · Chest · doi:10.1378/chest.06-1261 · Cited by 439
Clinical Prediction Model To Characterize Pulmonary Nodules
Herder, G. J., van Tinteren, H., Golding, R. P., Kostense, P. J., Comans, E. F., Smit, E. F., & Hoekstra, O. S. (2005) · Chest · doi:10.1378/chest.128.4.2490 · Cited by 387
Grutters, J. P. C., Kessels, A. G. H., Pijls-Johannesma, M., De Ruysscher, D., Joore, M. A., & Lambin, P. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.08.003 · Cited by 322
Natural History of Stage I Non-Small Cell Lung Cancer
Raz, D. J., Zell, J. A., Ou, S.-H. I., Gandara, D. R., Anton-Culver, H., & Jablons, D. M. (2007) · Chest · doi:10.1378/chest.06-3096 · Cited by 322
Janssen-Heijnen, M. L. G., Schipper, R. M., Razenberg, P. P. A., Crommelin, M. A., & Coebergh, J.-W. W. (1998) · Lung Cancer · doi:10.1016/s0169-5002(98)00039-7 · Cited by 295
Hurkmans, C. W., Cuijpers, J. P., Lagerwaard, F. J., Widder, J., van der Heide, U. A., Schuring, D., & Senan, S. (2009) · Radiation Oncology · doi:10.1186/1748-717x-4-1 · Cited by 287
Self-citationThe surgical management of elderly cancer patients
Audisio, R. A., Bozzetti, F., Gennari, R., Jaklitsch, M. T., Koperna, T., Longo, W. E., Wiggers, T., & Zbar, A. P. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.016 · Cited by 195
Turning Gray: The Natural History of Lung Cancer Over Time
Detterbeck, F. C., & Gibson, C. J. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31817c9230 · Cited by 176
Radiation Therapy for the Treatment of Unresected Stage I-II Non-small Cell Lung Cancer
Wisnivesky, J. P., Bonomi, M., Henschke, C., Iannuzzi, M., & McGinn, T. (2005) · Chest · doi:10.1378/chest.128.3.1461 · Cited by 172
Sanden, G. A. C. V. D., Coebergh, J.-W. W., Schouten, L. J., Visser, O., & Leeuwen, F. E. V. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00355-m · Cited by 160
Self-citationSex Differences in Lung Cancer Survival: Do Tumors Behave Differently in Elderly Women?
Wisnivesky, J. P., & Halm, E. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1455 · Cited by 159
Herder, G. J. M., Kramer, H., Hoekstra, O. S., Smit, E. F., Pruim, J., van Tinteren, H., Comans, E. F. I., Verboom, P., Groot, C. A. U., Welling, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.4695 · Cited by 148
Ageism in the management of lung cancer
Peake, M. D. (2003) · Age and Ageing · doi:10.1093/ageing/32.2.171 · Cited by 143
Nguyen, N. P., Garland, L. L., Welsh, J. S., et al. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.06.001 · Cited by 77
Gauden, S., & Tripcony, L. B. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00199-9 · Cited by 76
Pharmacology of antineoplastic agents in older cancer patients.
Lichtman, S. M., & Skirvin, J. A. (2000) · PubMed · Cited by 67
Effect of Age on Survival of Clinical Stage I Non-Small-Cell Lung Cancer
Sigel, K. M., Bonomi, M. R., Packer, S. H., & Wisnivesky, J. P. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0475-8 · Cited by 63
Pharmacology of antineoplastic agents in older cancer patients
Lichtman, S. M., Skirvin, J. A., & Vemulapalli, S. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00120-8 · Cited by 51
Cited by
Chang, J. Y., Senan, S., Paul, M. A., Mehran, R. J., Louie, A. V., Balter, P., Groen, H. J. M., McRae, S. E., Widder, J., Feng, L., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70168-3 · Cited by 1,462
Self-citation_, _. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0021 · Cited by 735
Vansteenkiste, J., Crinò, L., Dooms, C., Douillard, J. Y., Faivre-Finn, C., Lim, E., Rocco, G., Senan, S., Van Schil, P., Veronesi, G., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu089 · Cited by 493
Self-citationSenthi, S., Lagerwaard, F. J., Haasbeek, C. J., Slotman, B. J., & Senan, S. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70242-5 · Cited by 447
Self-citationRadiotherapy treatment for lung cancer: Current status and future directions
Vinod, S. K., & Hau, E. (2020) · Respirology · doi:10.1111/resp.13870 · Cited by 412
Metadata
- Authors
- Palma, D., Visser, O., Lagerwaard, F. J., Belderbos, J., Slotman, B. J., & Senan, S.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-12-10
- Volume
- 28
- Issue
- 35
- Pages
- 5153-5159
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2100101054
- Cited by
- 479
- References
- 26
- FWCI
- 24.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.